Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2515PDF: 1939HTML: 1095 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2725PDF: 927HTML: 9077Efremov 1: 279Efremov 2: 250 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5235PDF: 3032HTML: 2386 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3653PDF: 1497HTML: 2749 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3328PDF: 972HTML: 7327Kost Fig1: 234Kost Fig 2: 221Kost Fig3: 239Kost Fig 4: 247Kost Fig5: 245Kost fig 6: 233 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2421PDF: 960HTML: 2036Fig 1 Rossi: 252 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1542PDF: 883HTML: 1043 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2760PDF: 959HTML: 17624Fig1 Caligaris: 243Fig.2 Caliga: 278 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3524PDF: 1037HTML: 4983 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4238PDF: 1658HTML: 9332Untitled: 347Untitled: 232Untitled: 218Untitled: 234Untitled: 233Untitled: 394 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1941PDF: 1278HTML: 371 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3123PDF: 1113HTML: 5677 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2527PDF: 1410HTML: 17243Bassan Fig.1: 188Bassan Fig.2: 292Bassan Fig.4: 176Fig.3: 313 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4820PDF: 3965HTML: 383 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4505PDF: 2061HTML: 5571Table 1: 300 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3962PDF: 1748HTML: 116 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1773PDF: 711HTML: 2457 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1830PDF: 1179HTML: 201 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2449PDF: 1140HTML: 2041Characteristic of study group: 264 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1774HTML: 725PDF: 933 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1289PDF: 678Suppl. Files: 154HTML: 553 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4738PDF: 1834HTML: 1401 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2466PDF: 1093HTML: 7723Untitled: 331Fig2: 233Fig3: 227Fig4: 251 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3507PDF: 994HTML: 1564Fig.1 CHL-R paper: 269Fig 2 CHL-R paper: 312 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
2153PDF: 900HTML: 273 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3976PDF: 1720HTML: 893Figures . Eliassian: 333 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1656PDF: 1037HTML: 272 -
Osteolytic bone lesions – A rare presentation of AML M6.
2136PDF: 1228HTML: 8027Untitled: 256







